ClinicalTrials.govpublic full text
LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer
urinary bladder neoplasms, ureteral neoplasms, urethral neoplasms, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 846073
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.